EUVIMEDEUVIMED entdecken
Crossref

Biochanin A Attenuates Renal Fibrosis Via Selective Inhibition of Smad3‐mediated Epithelial‐Mesenchymal Transition in a Murine Unilateral Ureteral Obstruction Model

Huai-Ying Guo, Yu-Qing Li, Cong Wei, Shi-Yong Li, Jian-Chun Li, Chang-Ying Zhao, Qiong-Dan Hu, Hong-Wei Su, Hong-Ping Shen, Hong-Lian Wang iD, Li Wang

Cell Biology International · 2026-01 · 50 (1)

DOI: 10.1002/cbin.70098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biology International, online erschienen am 28.10.2025. Verfasst von Huai-Ying Guo und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Integrated Chinese and Western Medicine and the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Ch…. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Smad3 Protein, Ureteral Obstruction, Genistein. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: This study was supported by the Sichuan Science and Technology Program [No 2024NSFSC0689, 2022YFS0621, 2022YFS0635, 2022YFS0407, and 2022NSFSC1459]; the Luzhou….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal fibrosis driven by TGF‐β/Smad3 signaling is a critical factor in the advancement of chronic kidney disease, and partial epithelial‐to‐mesenchymal transition (EMT) in tubular cells plays a significant role in this process. In this study, we explored the reno‐protective role of biochanin A (BCA), a natural isoflavone, in mice with unilateral ureter obstruction (UUO) and in cultured renal tubular TCMK1 cells stimulated with the profibrotic cytokine TGF‐β1. Our results demonstrated that BCA (20 and 50 mg/kg) dose‐dependently ameliorated structural damage in UUO kidneys with reduced extracellular matrix deposition and downregulated levels of fibrotic genes Col1a1 , fibronectin , and α‐SMA . In vitro , BCA (5 and 10 μg/mL) also exhibited a dose‐dependent anti‐fibrosis effect in TCMK1 cells induced by TGF‐β1. Moreover, BCA prevented tubular partial EMT by mitigating the upregulation of mesenchymal marker genes N‐cadherin and vimentin in UUO kidneys and TGF‐β1‐induced TCMK1 cells. BCA treatment also reversed the reduced staining of Lotus Tetragonolobus Lectin and peanut agglutinin, two markers of mature renal tubular epithelia, in UUO kidneys. Mechanistically, BCA inhibited Smad2 and Smad3 phosphorylation and specifically downregulated Smad3 protein expression, without affecting Smad2, in TGF‐β1‐stimulated TCMK1 cells. Most importantly, in TGF‐β1‐treated TCMK1 cells, Smad3 overexpression abolished the anti‐fibrosis and anti‐EMT effects of BCA. In conclusion, our findings demonstrate the potential of BCA as a therapeutic agent against renal fibrosis by inhibiting TGF‐β/Smad3 signaling‐mediated tubular partial EMT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionSmad3 ProteinUreteral ObstructionGenisteinKidneyKidney DiseasesAnimalsFibrosisMiceDisease Models, AnimalMaleMice, Inbred C57BLSignal TransductionTransforming Growth Factor beta1Cell Line

Stichwörter der Autor:innen

Biochanin ASmad3TGF‐β signalingchronic kidney diseaserenal fibrosistubular partial EMT

Substanzen

Smad3 ProteinGenisteinSmad3 protein, mousebiochanin ATransforming Growth Factor beta1

Autor:innen und Institutionen

  • College of Integrated Chinese and Western Medicine and the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.
  • The Clinical Laboratory, the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.
  • Research Center for Integrative Medicine, the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.
  • Department of Endocrinology, the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.
  • Department of Nephrology, the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.
  • Department of Urology, the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.

ORCID-Profile: Hong-Lian Wang

Förderung

  • This study was supported by the Sichuan Science and Technology Program [No 2024NSFSC0689, 2022YFS0621, 2022YFS0635, 2022YFS0407, and 2022NSFSC1459]; the Luzhou…

Zitieren

APA

Guo, H. Y., Li, Y. Q., Wei, C., Li, S. Y., Li, J. C., Zhao, C. Y., Hu, Q. D., Su, H. W., Shen, H. P., Wang, H. L., & Wang, L. (2026). Biochanin A Attenuates Renal Fibrosis Via Selective Inhibition of Smad3‐mediated Epithelial‐Mesenchymal Transition in a Murine Unilateral Ureteral Obstruction Model. Cell Biology International, 50(1). https://doi.org/10.1002/cbin.70098

Vancouver

Guo HY, Li YQ, Wei C, Li SY, Li JC, Zhao CY, et al. Biochanin A Attenuates Renal Fibrosis Via Selective Inhibition of Smad3‐mediated Epithelial‐Mesenchymal Transition in a Murine Unilateral Ureteral Obstruction Model. Cell Biology International. 2026;50(1). doi:10.1002/cbin.70098

BibTeX
@article{Guo2026,
  author = {Guo, Huai-Ying and Li, Yu-Qing and Wei, Cong and Li, Shi-Yong and Li, Jian-Chun and Zhao, Chang-Ying and Hu, Qiong-Dan and Su, Hong-Wei and Shen, Hong-Ping and Wang, Hong-Lian and Wang, Li},
  title = {Biochanin A Attenuates Renal Fibrosis Via Selective Inhibition of Smad3‐mediated Epithelial‐Mesenchymal Transition in a Murine Unilateral Ureteral Obstruction Model},
  journal = {Cell Biology International},
  year = {2026},
  volume = {50},
  number = {1},
  doi = {10.1002/cbin.70098}
}
Kostenlos starten →